KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Procter & Gamble (PG) Raw Materials (2016 - 2025)

Historic Raw Materials for Procter & Gamble (PG) over the last 17 years, with Q4 2025 value amounting to $2.1 billion.

  • Procter & Gamble's Raw Materials rose 974.86% to $2.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.1 billion, marking a year-over-year increase of 974.86%. This contributed to the annual value of $2.0 billion for FY2025, which is 2504.64% up from last year.
  • Per Procter & Gamble's latest filing, its Raw Materials stood at $2.1 billion for Q4 2025, which was up 974.86% from $2.1 billion recorded in Q3 2025.
  • In the past 5 years, Procter & Gamble's Raw Materials ranged from a high of $2.2 billion in Q3 2022 and a low of $1.5 billion during Q1 2021
  • Its 5-year average for Raw Materials is $1.9 billion, with a median of $1.9 billion in 2024.
  • In the last 5 years, Procter & Gamble's Raw Materials soared by 3863.05% in 2022 and then crashed by 2129.75% in 2023.
  • Quarter analysis of 5 years shows Procter & Gamble's Raw Materials stood at $2.1 billion in 2021, then increased by 8.3% to $2.2 billion in 2022, then dropped by 20.25% to $1.8 billion in 2023, then increased by 9.49% to $1.9 billion in 2024, then rose by 9.75% to $2.1 billion in 2025.
  • Its Raw Materials stands at $2.1 billion for Q4 2025, versus $2.1 billion for Q3 2025 and $2.0 billion for Q2 2025.